Targeted delivery of extracellular vesicles in heart injury

Chen, Peier; Wang, Ling; Fan, Xianglin; Ning, Xiaodong; Yu, Bin; Ou, Caiwen; Chen, Minsheng

doi:10.7150/thno.51571



Nanotheranostics 2024; 8(3): 380-400. [Abstract] [Full text] [PDF]

Nanotheranostics 2024; 8(3): 344-379. [Abstract] [Full text] [PDF] [PubMed] [PMC]

Nanotheranostics

International Journal of Biological Sciences

International Journal of Medical Sciences

Journal of Cancer

Global reach, higher impact

Full Text | PDF

Theranostics 2021; 11(5):2263-2277. doi:10.7150/thno.51571 This issue Cite

Review

Targeted delivery of extracellular vesicles in heart injury

Peier Chen^1,2,3, Ling Wang⁴, Xianglin Fan^1,2,3, Xiaodong Ning^1,2,3, Bin Yu^1,2,3, Caiwen Ou^1,2,3✉, Minsheng Chen^1,2,3✉

1. Laboratory of Heart Center and Department of Cardiology, Zhujiang Hospital, Southern Medical University, Guangzhou, China.
2. Guangdong Provincial Biomedical Engineering Technology Research Center for Cardiovascular Diseases, Guangzhou, China.
3. Laboratory of Heart Center, Sino-Japanese Cooperation Platform for Translational Research in Heart Failure, Guangzhou, China.
4. Biomaterials Research Center, School of Biomedical Engineering, Southern Medical University, Guangzhou 510515, China.

Citation:

Chen P, Wang L, Fan X, Ning X, Yu B, Ou C, Chen M. Targeted delivery of extracellular vesicles in heart injury. Theranostics 2021; 11(5):2263-2277. doi:10.7150/thno.51571. https://www.thno.org/v11p2263.htm

Other styles

Abstract

Extracellular vesicles (EVs) are nanoscale extracellular vesicles derived from endocytosis that are crucial to intercellular communication. EVs possess natural biocompatibility and stability that allow them to cross biological membranes and that protect them from degradation. Recent studies have shown that EVs-mediated crosstalk between different cell types in the heart could play important roles in the maintenance of cardiac homeostasis and the pathogenesis of heart diseases. In particular, EVs secreted by different types of stem cells exhibit cardioprotective effects. However, numerous studies have shown that intravenously injected EVs are quickly cleared by macrophages of the mononuclear phagocyte system (MPS) and preferentially accumulate in MPS organs such as the liver, spleen, and lung. In this review, we discuss exosome biogenesis, the role of EVs in heart diseases, and challenges in delivering EVs to the heart. Furthermore, we extensively discuss the targeted delivery of EVs for treating ischemic heart disease. These understandings will aid in the development of effective treatment strategies for heart diseases.

Keywords: Extracellular Vesicles, Biogenesis, Heart Injury, Challenges, Targeted Delivery

Citation styles

APA

Chen, P., Wang, L., Fan, X., Ning, X., Yu, B., Ou, C., Chen, M. (2021). Targeted delivery of extracellular vesicles in heart injury. Theranostics, 11(5), 2263-2277. https://doi.org/10.7150/thno.51571.

ACS

Chen, P.; Wang, L.; Fan, X.; Ning, X.; Yu, B.; Ou, C.; Chen, M. Targeted delivery of extracellular vesicles in heart injury. Theranostics 2021, 11 (5), 2263-2277. DOI: 10.7150/thno.51571.

NLM

CSE

Chen P, Wang L, Fan X, Ning X, Yu B, Ou C, Chen M. 2021. Targeted delivery of extracellular vesicles in heart injury. Theranostics. 11(5):2263-2277.

This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/). See http://ivyspring.com/terms for full terms and conditions.